Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

PURPOSE: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) form a rare and remarkably heterogeneous group of tumors. Therefore, establishing personalized therapies is eminently challenging. To achieve progress in preclinical drug development, there is an urgent need for relevant tumor models...

Descripción completa

Detalles Bibliográficos
Autores principales: Viol, Fabrice, Sipos, Bence, Fahl, Martina, Clauditz, Till S., Amin, Tania, Kriegs, Malte, Nieser, Maike, Izbicki, Jakob R., Huber, Samuel, Lohse, Ansgar W., Schrader, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747820/
https://www.ncbi.nlm.nih.gov/pubmed/36269546
http://dx.doi.org/10.1007/s13402-022-00727-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747820/
https://www.ncbi.nlm.nih.gov/pubmed/36269546
http://dx.doi.org/10.1007/s13402-022-00727-z

Ejemplares similares